2016 US lymphoid malignancy statistics by World Health Organization subtypes.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 27618563)

Published in CA Cancer J Clin on September 12, 2016

Authors

Lauren R Teras1, Carol E DeSantis2, James R Cerhan3, Lindsay M Morton4, Ahmedin Jemal5, Christopher R Flowers6

Author Affiliations

1: Strategic Director, Hematologic Cancer Research, Epidemiology Research Program, American Cancer Society, Atlanta, GA. lauren.teras@cancer.org.
2: Director, Breast and Gynecological Cancer Surveillance, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA.
3: Professor and Chair, Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
4: Senior Investigator, Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD.
5: Vice President, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA.
6: Director, Lymphoma Program, Department of Hematology and Oncology/Winship Cancer Institute, Emory University, Atlanta, GA.

Associated clinical trials:

A Disease Registry of Patients With Mantle Cell Lymphoma (SUMMIT) | NCT03816683